BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 3011318)

  • 1. IgG thyrotrophin receptor antibody activity in Graves' disease; a study of TSH agonist and antagonist activities by isoelectric focusing.
    Creagh FM; Howells RD; Williams S; Didcote S; Hashim FA; Petersen VB; Rees Smith B
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):79-88. PubMed ID: 3011318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSH receptor binding and thyroid stimulation by sera from patients with Graves' disease.
    Ginsberg J; Shewring G; Smith BR
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):305-11. PubMed ID: 6138173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of iodine organification in porcine thyroid cells by thyroid stimulators.
    Ginsberg J; Shewring G; Howells R; Smith BR; Hall R
    Life Sci; 1983 Jan 3-10; 32(1-2):153-60. PubMed ID: 6298541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprecipitation of TSH-TSH receptor complexes.
    Parkes AB; Kajita Y; Buckland PR; Howells RD; Rickards CR; Creagh FM; Rees Smith B
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):511-20. PubMed ID: 2985304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibodies causing thyroid stimulating hormone-binding inhibition (TSH-BI) are not responsible for the specific inhibition of gonadal steroidogenesis by Graves' sera.
    Castel MA; Willey KP; Hunt N; Leidenberger F
    J Reprod Immunol; 1996 Feb; 30(1):1-15. PubMed ID: 8920164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
    Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
    Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
    Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocyte-TSH-receptor-related antibodies in Graves' disease detected by immunoprecipitation.
    Konishi J; Iida Y; Kasagi K; Ikekubo K; Kuma K; Torizuka K
    Endocrinol Jpn; 1982 Apr; 29(2):219-26. PubMed ID: 6127208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.
    Saiki Y; Ishihara T; Ikekubo K; Mori T
    Endocr J; 2005 Feb; 52(1):45-55. PubMed ID: 15758557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-TSH receptor antibodies in Graves' disease modulate the kinetic behaviour of autologous thyroid TSH receptors. Evidence of the IgG-induced cross-linkage of autologous TSH receptors.
    de Bruin TW; van der Heide D
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):330-40. PubMed ID: 6322495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithyrotropin antibodies in the sera of Graves' disease patients.
    Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD
    J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-thyrotrophin receptor antibodies in Graves' disease as demonstrated directly by immunoprecipitation assay.
    de Bruin TW; van der Heide D
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):49-56. PubMed ID: 6297216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
    Morris JC; Hay ID; Nelson RE; Jiang NS
    Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterogeneous in epitope recognition.
    Ueda Y; Sugawa H; Akamizu T; Okuda J; Ueda M; Kosugi S; Ohta C; Kihou Y; Mori T
    Eur J Endocrinol; 1995 Jan; 132(1):62-8. PubMed ID: 7531576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum protein inhibition of thyrotropin binding to human thyroid tissue.
    Beall GN; Chopra IJ; Solomon DH; Kruger SR
    J Clin Endocrinol Metab; 1978 Nov; 47(5):967-73. PubMed ID: 45474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y; Hamazu M; Kajita Y; Nagata A
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.